Yuying Zhang1, Rose Ting1, Marco Lam2, Joyce Lam2, Hairong Nan3, Roseanne Yeung4, Wenying Yang5, Linong Ji6, Jianping Weng7, Yun-Kwok Wing2, Norman Sartorius8, Juliana C N Chan9. 1. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region. 2. Department of Psychiatry, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region. 3. Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region. 4. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region; Division of Endocrinology, University of British Columbia, Canada. 5. Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China. 6. Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China. 7. Department of Endocrinology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. 8. Association for the Improvement of Mental Health Programmes, Geneva, Switzerland. 9. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region. Electronic address: jchan@cuhk.edu.hk.
Abstract
BACKGROUND: Depression is common in type 2 diabetes although the prevalence in Chinese patients remains unclear. We validated the Patient Health Questionnaire(PHQ-9), a popular depression screening tool, in Chinese with type 2 diabetes, and documented the prevalence, demographic,and clinical characteristics associated with depression. METHODS: A consecutive cohort of 586 Hong Kong Chinese outpatients completed the PHQ-9 during comprehensive diabetes complication assessment. Within 2-4 weeks, 40 patients were retested via telephone survey. Ninety-nine randomly selected patients were interviewed by psychiatrists using the Mini International Neuropsychiatric Interview as a golden standard. Receiver operating characteristic curve was used to assess performance of the PHQ-9. RESULTS: The internal consistency of the PHQ-9 was 0.86 and test-retest reliability was 0.70. The 3 somatic items explained 53.6% of the PHQ-9 score. The optimal cutoff value was 7 with 82.6% sensitivity and 73.7% specificity, giving a depression prevalence of 18.3% (n=107). Of these, 18.7% had been previously diagnosed with depression. Depression was more prevalent in women than men. After controlling for confounders, patients with depression had higher HbA1c (7.80 ± 1.86% versus 7.43 ± 1.29%, [61.7 ± 20.4 versus 57.8 ± 14.1 mmol/mol], P<0.05), reduced likelihood of achieving HbA1c target of <7.0% (33.6% versus 41.8%, P<0.05), and were more likely to have self-reported hypoglycemia in the previous 3 months (18.7% versus 6.7%, P<0.01). LIMITATION: A small sample was used in the criterion validation and the cross-sectional design precludes causal inference. CONCLUSIONS: PHQ-9 is a validated tool for screening for depression, which is common and frequently undiagnosed in Chinese type 2 diabetic patients and is associated with suboptimal glycemic control, hypoglycemia, and somatization.
BACKGROUND:Depression is common in type 2 diabetes although the prevalence in Chinese patients remains unclear. We validated the Patient Health Questionnaire(PHQ-9), a popular depression screening tool, in Chinese with type 2 diabetes, and documented the prevalence, demographic,and clinical characteristics associated with depression. METHODS: A consecutive cohort of 586 Hong Kong Chinese outpatients completed the PHQ-9 during comprehensive diabetes complication assessment. Within 2-4 weeks, 40 patients were retested via telephone survey. Ninety-nine randomly selected patients were interviewed by psychiatrists using the Mini International Neuropsychiatric Interview as a golden standard. Receiver operating characteristic curve was used to assess performance of the PHQ-9. RESULTS: The internal consistency of the PHQ-9 was 0.86 and test-retest reliability was 0.70. The 3 somatic items explained 53.6% of the PHQ-9 score. The optimal cutoff value was 7 with 82.6% sensitivity and 73.7% specificity, giving a depression prevalence of 18.3% (n=107). Of these, 18.7% had been previously diagnosed with depression. Depression was more prevalent in women than men. After controlling for confounders, patients with depression had higher HbA1c (7.80 ± 1.86% versus 7.43 ± 1.29%, [61.7 ± 20.4 versus 57.8 ± 14.1 mmol/mol], P<0.05), reduced likelihood of achieving HbA1c target of <7.0% (33.6% versus 41.8%, P<0.05), and were more likely to have self-reported hypoglycemia in the previous 3 months (18.7% versus 6.7%, P<0.01). LIMITATION: A small sample was used in the criterion validation and the cross-sectional design precludes causal inference. CONCLUSIONS: PHQ-9 is a validated tool for screening for depression, which is common and frequently undiagnosed in Chinese type 2 diabeticpatients and is associated with suboptimal glycemic control, hypoglycemia, and somatization.
Authors: Boliang Guo; Catherine Kaylor-Hughes; Anne Garland; Neil Nixon; Tim Sweeney; Sandra Simpson; Tim Dalgleish; Rajini Ramana; Min Yang; Richard Morriss Journal: J Affect Disord Date: 2017-05-08 Impact factor: 4.839
Authors: Kai Lu; Rongjing Ding; Qin Tang; Jia Chen; Li Wang; Changying Wang; Shouling Wu; Dayi Hu Journal: Int J Environ Res Public Health Date: 2015-01-07 Impact factor: 3.390
Authors: Anne Rutte; Patricia van Oppen; Giel Nijpels; Frank J Snoek; Paul Enzlin; Peter Leusink; Petra J M Elders Journal: BMC Fam Pract Date: 2015-06-02 Impact factor: 2.497
Authors: Yuying Zhang; Rose Z W Ting; Marco H B Lam; Siu-Ping Lam; Roseanne O Yeung; Hairong Nan; Risa Ozaki; Andrea O Y Luk; Alice P S Kong; Yun-Kwok Wing; Norman Sartorius; Juliana C N Chan Journal: BMC Psychiatry Date: 2015-08-18 Impact factor: 3.630